» Articles » PMID: 30404976

Comparison of Characteristics and 3-Year Outcomes in Patients With Acute Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction

Abstract

Background: The clinical characteristics and outcomes of acute heart failure (AHF) according to left ventricular ejection fraction (LVEF) have not been fully elucidated, especially for patients with mid-range LVEF. We performed a comprehensive comparison of the epidemiology, patterns of in-hospital management, and clinical outcomes in AHF patients with different LVEF categories.

Methods and results: The Korean Acute Heart Failure (KorAHF) registry is a prospective multicenter cohort of hospitalized AHF patients in Korea. A total of 5,374 patients enrolled in the KorAHF registry were classified according to LVEF based on the 2016 ESC guidelines. More than half of the HF patients (58%) had reduced EF (HFrEF), 16% had mid-range EF (HFmrEF), and 25% had preserved EF (HFpEF). The HFmrEF patients showed intermediate epidemiological profiles between HFrEF and HFpEF and had a propensity to present as de-novo HF with ischemic etiology. Patients with lower LVEF had worse short-term outcomes, and the all-cause in-hospital mortality, including urgent heart transplantation, of HFrEF, HFmrEF, and HFpEF was 7.1%, 3.6%, and 3.0%, respectively. Overall, discharged AHF patients showed poor 3-year all-cause death up to 38%, which was comparable between LVEF subgroups (P=0.623).

Conclusions: Each LVEF subgroup of AHF patients was a heterogeneous population with diverse characteristics, which have a significant effect on the clinical outcomes. This finding suggested that focused phenotyping of AHF patients could help identify the optimal management strategy and develop novel effective therapies.

Citing Articles

Two-year clinical outcome of patients with mildly reduced ejection fraction after acute myocardial infarction: insights from the prospective KAMIR-NIH Registry.

Jeon H, Lee J, Moon J, Kang D, Lee J, Youn Y Front Cardiovasc Med. 2024; 11:1458740.

PMID: 39371398 PMC: 11451438. DOI: 10.3389/fcvm.2024.1458740.


Blood pressure and heart failure: focused on treatment.

Chun K, Kang S Clin Hypertens. 2024; 30(1):15.

PMID: 38822445 PMC: 11143661. DOI: 10.1186/s40885-024-00271-y.


Differentiating Characteristics and Responses to Treatment of New-Onset Heart Failure With Preserved and Reduced Ejection Fraction in Ambulatory Patients.

Alhadramy O, Alahmadi R, Alameen A, Ashmawi N, Alrehaili N, Afandi R Cardiol Res. 2023; 14(3):201-210.

PMID: 37304918 PMC: 10257507. DOI: 10.14740/cr1483.


Ejection fraction at hospital admission stratifies mortality risk in HFmrEF patients aged ≥ 70 years: a retrospective analysis from a tertiary university institution.

Sonaglioni A, Lonati C, Behring M, Nicolosi G, Lombardo M, Harari S Aging Clin Exp Res. 2023; 35(8):1679-1693.

PMID: 37277547 PMC: 10241373. DOI: 10.1007/s40520-023-02454-3.


Acute heart failure with mildly reduced ejection fraction and myocardial infarction: a multi-institutional cohort study.

Lin M, Wang P, Lin M, Kuo T, Lin Y, Chen T BMC Cardiovasc Disord. 2023; 23(1):272.

PMID: 37221514 PMC: 10207615. DOI: 10.1186/s12872-023-03286-9.